Published in PLoS Med on March 10, 2015
Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design. Viruses (2015) 0.84
Need of righteous attitudes towards eradication of hepatitis C virus infection in Latin America. World J Gastroenterol (2016) 0.80
RELATIONSHIP BETWEEN UVEITIS, DIFFERENT TYPES OF VIRAL HEPATITIS, AND LIVER CIRRHOSIS: A 12-Year Nationwide Population-Based Cohort Study. Retina (2016) 0.75
Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals. Pharmgenomics Pers Med (2017) 0.75
Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent Era. PLoS One (2016) 0.75
Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda. BMC Infect Dis (2017) 0.75
A 2015 roadmap for the management of hepatitis C virus infections in Asia. Korean J Intern Med (2015) 0.75
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology (2013) 12.46
Towards an improved investment approach for an effective response to HIV/AIDS. Lancet (2011) 11.89
Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology (1994) 9.86
High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science (2013) 8.24
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA (2012) 7.62
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep (2012) 6.91
Treatment of hepatitis C: a systematic review. JAMA (2014) 4.99
The effect of tuberculosis control in China. Lancet (2004) 4.84
Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol (2014) 4.82
Current and future therapies for hepatitis C virus infection. N Engl J Med (2013) 4.25
Global distribution and prevalence of hepatitis C virus genotypes. Hepatology (2014) 3.95
Redefining global health-care delivery. Lancet (2013) 3.89
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int (2011) 3.69
Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review. Ann Intern Med (2013) 3.39
Natural history of hepatitis C. Clin Liver Dis (2005) 3.34
Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis (2002) 3.19
Mandatory reporting of diseases and conditions by health care professionals and laboratories. JAMA (1999) 2.90
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int (2011) 2.77
Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. Hepatology (2013) 2.76
Interim measures for meeting needs for health sector data: births, deaths, and causes of death. Lancet (2007) 2.71
Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol (2004) 2.58
Laboratory challenges in the scaling up of HIV, TB, and malaria programs: The interaction of health and laboratory systems, clinical research, and service delivery. Am J Clin Pathol (2009) 2.40
Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211): a modelling study. Lancet Glob Health (2014) 2.15
Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association. Epidemiol Infect (2013) 2.09
Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clin Infect Dis (2009) 2.01
The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis (2013) 1.99
Accuracy of rapid and point-of-care screening tests for hepatitis C: a systematic review and meta-analysis. Ann Intern Med (2012) 1.90
Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis (2005) 1.90
Antiviral treatment of hepatitis C. BMJ (2014) 1.61
Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis. Clin Infect Dis (2013) 1.61
Systematic review of the use of dried blood spots for monitoring HIV viral load and for early infant diagnosis. PLoS One (2014) 1.55
Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. Clin Infect Dis (2013) 1.38
Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis. Am J Transplant (2011) 1.31
Trends and projections of hepatitis C virus epidemiology in Latin America. Liver Int (2011) 1.31
Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS. Clin Infect Dis (2012) 1.30
Incidence of acute hepatitis C virus infection among men who have sex with men with and without HIV infection: a systematic review. Sex Transm Infect (2012) 1.25
Treatment as prevention and cure towards global eradication of hepatitis C virus. Trends Microbiol (2013) 1.14
Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward). J Viral Hepat (2014) 1.13
Minimum target prices for production of direct-acting antivirals and associated diagnostics to combat hepatitis C virus. Hepatology (2015) 1.10
Dried blood spot for hepatitis C virus serology and molecular testing. Hepatology (2010) 1.05
Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) core antigen test with the HCV RNA assay for clinical usefulness in confirming anti-HCV results. J Clin Microbiol (2011) 1.03
Percutaneous injuries before and after the Needlestick Safety and Prevention Act. N Engl J Med (2012) 1.00
Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Infect Dis (2014) 1.00
Trends in HCV RNA testing among HCV antibody-positive persons in care, 2003-2010. Clin Infect Dis (2014) 0.92
Therapy-induced clearance of HCV core antigen from plasma predicts an end of treatment viral response. J Viral Hepat (2012) 0.90
Global Fund investments in harm reduction from 2002 to 2009. Int J Drug Policy (2012) 0.83
Risky behavior and correlates of HIV and Hepatitis C Virus infection among people who inject drugs in three cities in Afghanistan. Drug Alcohol Depend (2014) 0.80